Project Grant R35GM158073

Award Date 8/1/25
Completion Date 7/31/30
Dollars Obligated $275K
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Connecticut, USA
Similar Awards
The National Institute of General Medical Sciences (NIGMS) awarded a $440,000 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to the Sloan-Kettering Institute for Cancer Research in New York. The 5-year grant, awarded on February 3, 2025, supports advanced research to decode the ubiquitin and autophagy signaling networks, which are essential cellular processes involved in proteome homeostasis. The research program combines expertise in quantitative mass spectrometry,...
The National Institute of General Medical Sciences (NIGMS) awarded a $528,000 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to the Sloan-Kettering Institute for Cancer Research located in New York, NY. The purpose of this 4-year grant, with a period of performance from September 30, 2024 to July 31, 2028, is to develop novel approaches to map the folding and protein occupancy of entire chromosomes with single-nucleosome resolution and single-molecule precision. The...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training federal grant program (CFDA 93.859), is funding research at Brigham Young University (BYU) to develop advanced mass spectrometry-based technologies for profiling biomolecular expression at the single-cell level. The $1,317,836 award, with a project period from September 1, 2024 to July 31, 2029, will support the development of global and targeted...
The National Institute of General Medical Sciences (NIGMS) awarded a $627,797 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to Cornell University, effective May 1, 2025 through April 30, 2030. The goal of this research program is to delineate the inner workings of membrane-associated protein complexes that shape the form and function of tissues, and whose dysfunction leads to serious human diseases. The research leverages a multi-disciplinary approach...
The National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), awarded a $780,000 Project Grant to Oregon Health & Science University (OHSU) effective September 1, 2024 through July 31, 2029. The grant supports the development of innovative proteomic tools to study transcription factor-coregulator interactions and their role in gene regulation, cellular differentiation, and disease progression. Key objectives include...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) provides $401,571 to Yale University to conduct research on probing the structures and hydration of biopolymers, such as proteins, DNA, and RNA, at aqueous interfaces using chiral-selective vibrational sum frequency generation (chiral SFG) spectroscopy. The key objectives of this 5-year project are to investigate how the asymmetric chemical...
The National Institute of General Medical Sciences (NIGMS) awarded a $645,712 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to the Trustees of Tufts College in Medford, MA. The grant supports the development of new chemical biology tools to study protein post-translational modifications, specifically glycation and ubiquitination, in living cells. The research aims to uncover how these modifications are integrated into cellular signaling networks and...
The National Institute of General Medical Sciences (NIGMS) awarded a $243,840 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to the University of Pittsburgh. The project, titled "An Effective Statistical Inference Framework to Develop Innovative Compensations for Protein Mutations," aims to develop quantitative methods for predicting the impact of protein mutations and identifying compensatory mutations that can restore normal protein...
The National Institute of General Medical Sciences (NIGMS) awarded a $470,000 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to The Institute For Cancer Research, a non-profit subsidiary of Temple University, for a 5-year research project starting on September 17, 2024. The goal of the project is to characterize the molecular-level interactions and coordination events coupling the repair of oxidative DNA damage and gene enhancement at G-quadruplex promoter regions in...
This $1,259,550 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) will fund a 5-year research project at the University of Washington to study the role of protein phosphorylation in regulating the cellular proteome. The research aims to: 1) identify phosphorylation sites relevant to protein function at a proteomic scale, 2) examine how phosphorylation regulates multi-level proteome organization,...

The National Institute of General Medical Sciences (NIGMS) awarded a $274,597 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to Yale University. The 5-year grant, effective August 1, 2025, supports research on proteomic and phosphoproteomic remodeling under genomic imbalance, or aneuploidy. The project aims to study the mechanisms of protein regulation and signaling pathways in aneuploid cells, with a focus on distinguishing the effects of chromosome gain versus loss, characterizing phosphorylation changes, and adopting a cross-species approach. The research leverages advanced mass spectrometry techniques to measure protein abundance, lifetime, and post-translational modifications in order to advance the understanding of genome imbalance stress and associated abnormalities.

Generated 8/5/25, 6:05 AM